Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating (Predict4All)

Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating - Predict4All

The main objective of the PREDICT4ALL project is to provide written communication in a computer, reducing the number of spelling errors for each user.

The effectiveness of written communication is defined in this study by the number of spelling errors for each user. Word prediction (and therefore correction) must be able to be configured by a therapist (speech therapist, occupational therapist).

Adapting the prediction to user errors should also allow it to be more relevant throughout the text input. This software efficiency must increase text input speed, Reduce the cognitive load, establish a classification of spelling errors adapted to the context of text input speed and develop the word prediction module tolerant of these spelling errors.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Garches, France, 92380
        • Raymond Poincaré Hospital
      • Ploemeur, France, 56270
        • CMRRF Kerpape

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 25 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 6 and 25 years old For center 1
  • patient with dysorthographia
  • educational level greater than or equal to CE2
  • A developmental level in reading on the Evalouette test (Evaleo battery) greater than or equal to CE1 For center 2
  • Neurologic disorder impacting communication

Exclusion Criteria:

  • Patient's refusal to participate in the study
  • Persons under guardianship
  • Pregnant women
  • No affiliation to a social security scheme (beneficiary or beneficiary)
  • Having visual disturbances preventing the use of the computer tool

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: classic prediction software
test with classic precition software
test with prediction software with spell checker
EXPERIMENTAL: prediction software with spell checker
test with prediction software with spell checker
test with prediction software with spell checker

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of spelling errors
Time Frame: 20 min
total of number of spelling errors during the test
20 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Text input speed
Time Frame: 20 min
Text input speed in the test
20 min
Prediction usage rate
Time Frame: 20 min
number of times the prediction is used
20 min
Keystrokes Saving Rate
Time Frame: 5 min
measured by the percentage of input saved by word prediction versus a keyboard alone
5 min
Attentional load
Time Frame: 1 min
Likert Analog Visual Scale [0-10]
1 min
Fatigue
Time Frame: 1 min
Likert Analog Visual Scale [0-10]
1 min
software Satisfaction
Time Frame: 1 min
Likert Analog Visual Scale [0-10]
1 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 13, 2020

Primary Completion (ACTUAL)

March 8, 2022

Study Completion (ACTUAL)

March 8, 2022

Study Registration Dates

First Submitted

December 23, 2019

First Submitted That Met QC Criteria

December 24, 2019

First Posted (ACTUAL)

December 26, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 9, 2022

Last Update Submitted That Met QC Criteria

March 8, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-A01882-55

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurologic Disorder

Clinical Trials on prediction software with spell checker

3
Subscribe